Study to Assess the Clinical Efficacy and Safety of Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321) in Patients With Branch Retinal Vein Occlusion (BRVO)
Clinical trial NCT01521559 · COMPLETED
Trial details
- NCT number
- NCT01521559
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-01
- Primary completion
- 2013-08-01
- Enrollment
- 183
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.